BlueScope takes out defence science collaboration award

BlueScope Steel and its research partners have taken out the Defence Science and Technology Enterprise Collaboration award for 2022 – the inaugural year for the Department of Defence’s new More, Together awards for excellence. Announced at the Australian Defence Science, Technology and Research Summit, the inaugural three awards celebrate the outstanding achievements of organisations, teams…

Incannex to trial drug for inflammatory conditions

Melbourne cannabinoid and psychedelic medicine manufacturer Incannex Healthcare will go ahead with phase 1 clinical trials of its combination anti-inflammatory pharmaceutical IHL-675A for the treatment of rheumatoid arthritis, inflammatory bowel disease and lung inflammation. IHL-675A is a combination cannabinoid drug comprising cannabidiol (‘CBD’) and hydroxychloroquine (‘HCQ’) which the company said outperforms either CBD and HCQ…